InspireMD

NSPR

Tel Aviv, Israel· Est. 2005

Developer of the CGuard™ Embolic Prevention System, a proprietary stent platform designed to prevent stroke during carotid artery procedures.

inspiremd.com

Is this your company? Claim your profile to update info and connect with investors.

Claim profile

AI Company Overview

Developer of the CGuard™ Embolic Prevention System, a proprietary stent platform designed to prevent stroke during carotid artery procedures.

Cardiovascular

Technology Platform

MicroNet® technology, a proprietary micron-level mesh covering integrated into stent systems designed to trap embolic debris and prevent stroke during vascular procedures.

Opportunities

Significant growth opportunity exists in gaining FDA approval for the U.S.

carotid artery stenting market and expanding the application of its MicroNet® technology to coronary or peripheral vascular interventions.

Risk Factors

Key risks include regulatory delays in obtaining U.S.

FDA approval, intense competition from larger, well-capitalized medical device companies, and the challenge of achieving widespread market adoption against established standards of care.

Competitive Landscape

Competes with major medical device firms like Abbott and Boston Scientific in the carotid stenting market. Its primary differentiation is the embolic protection provided by its proprietary MicroNet® covering, which aims to reduce peri-procedural stroke risk compared to traditional open-cell stent designs.

More companies in Israel →